Growth Hormone or Sildenafil as Therapies for Fatigue in MTBI
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2018
Price : $35 *
At a glance
- Drugs Sildenafil (Primary) ; Somatrogon (Primary)
- Indications Somatotropin deficiency; Traumatic brain injuries
- Focus Therapeutic Use
- 01 Feb 2018 Status changed from active, no longer recruiting to completed.
- 26 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 15 Jul 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.